RCC is a vascular-rich tumor [27], mainly due to inactivation of the mutant gene VHL, leading to an abnormal accumulation of HIF-1/2α and initiating an angiogenic program with elevated levels of VEGF. Here, SETD2 is linked to renal cell carcinoma.